BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33737712)

  • 1. Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model.
    Sharma J; Collins TD; Roach T; Mishra S; Lam BK; Mohamed ZS; Veal AE; Polk TB; Jones A; Cornaby C; Haider MI; Zeumer-Spataro L; Johnson HM; Morel LM; Larkin J
    Sci Rep; 2021 Mar; 11(1):6354. PubMed ID: 33737712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.
    Rankin AL; Guay H; Herber D; Bertino SA; Duzanski TA; Carrier Y; Keegan S; Senices M; Stedman N; Ryan M; Bloom L; Medley Q; Collins M; Nickerson-Nutter C; Craft J; Young D; Dunussi-Joannopoulos K
    J Immunol; 2012 Feb; 188(4):1656-67. PubMed ID: 22231702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain.
    Neumann D; Del Giudice E; Ciaramella A; Boraschi D; Bossù P
    J Immunol; 2001 Mar; 166(6):3757-62. PubMed ID: 11238617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E; Lenda DM; Kelley VR
    J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-10 regulates murine lupus.
    Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J
    J Immunol; 2002 Aug; 169(4):2148-55. PubMed ID: 12165544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
    Lucas JA; Menke J; Rabacal WA; Schoen FJ; Sharpe AH; Kelley VR
    J Immunol; 2008 Aug; 181(4):2513-21. PubMed ID: 18684942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.
    Yang CH; Tian L; Ling GS; Trendell-Smith NJ; Ma L; Lo CK; Stott DI; Liew FY; Huang FP
    Eur J Immunol; 2008 Jun; 38(6):1664-76. PubMed ID: 18465774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of SOCS1-/- lethal autoinflammatory disease correlated to enhanced peripheral Foxp3+ regulatory T cell homeostasis.
    Collins EL; Jager LD; Dabelic R; Benitez P; Holdstein K; Lau K; Haider MI; Johnson HM; Larkin J
    J Immunol; 2011 Sep; 187(5):2666-76. PubMed ID: 21788442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.
    Rohraff DM; He Y; Farkash EA; Schonfeld M; Tsou PS; Sawalha AH
    Arthritis Rheumatol; 2019 Oct; 71(10):1681-1690. PubMed ID: 31106974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
    Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
    Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
    J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of reciprocal Lmb1-4 interval MRL-Faslpr and C57BL/6-Faslpr congenic mice reveals significant effects from Lmb3.
    Santiago-Raber ML; Haraldsson MK; Theofilopoulos AN; Kono DH
    J Immunol; 2007 Jun; 178(12):8195-202. PubMed ID: 17548658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.
    Fujita Y; Fujii T; Mimori T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Tanaka M; Masaki Y; Fukushima T; Okazaki T; Umehara H
    J Immunol; 2014 Feb; 192(3):979-84. PubMed ID: 24391210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice.
    Wu WM; Suen JL; Lin BF; Chiang BL
    Immunology; 2000 May; 100(1):110-8. PubMed ID: 10809966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin K Deficiency Ameliorates Systemic Lupus Erythematosus-like Manifestations in
    Zhou Y; Chen H; Liu L; Yu X; Sukhova GK; Yang M; Kyttaris VC; Stillman IE; Gelb B; Libby P; Tsokos GC; Shi GP
    J Immunol; 2017 Mar; 198(5):1846-1854. PubMed ID: 28093526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.
    Shimp SK; Chafin CB; Regna NL; Hammond SE; Read MA; Caudell DL; Rylander M; Reilly CM
    Cell Mol Immunol; 2012 May; 9(3):255-66. PubMed ID: 22543833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes.
    Ilangumaran S; Ramanathan S; La Rose J; Poussier P; Rottapel R
    J Immunol; 2003 Sep; 171(5):2435-45. PubMed ID: 12928391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS).
    Katzav A; Kloog Y; Korczyn AD; Niv H; Karussis DM; Wang N; Rabinowitz R; Blank M; Shoenfeld Y; Chapman J
    Clin Exp Immunol; 2001 Dec; 126(3):570-7. PubMed ID: 11737078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.